Latest Posts › Regulatory Agenda

Share:

COVID-19 Key EU Developments, Policy & Regulatory Update No. 66

Competition - European Commission comments on the future of competition policy - On 29 October 2021, Executive Vice-President and Competition Commissioner Margrethe Vestager provided remarks on the future of competition...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 65

Competition - European Commission ramps up combat against cartels, including reigniting dawn raids - On 22 October 2021, Executive Vice-President and Commissioner for Competition Margrethe Vestager highlighted the...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 64

European Commission adopts Communication on Energy Prices to tackle exceptional rise in energy prices - On 13 October 2021, the Commission adopted a Communication on Tackling Rising Energy Prices: a Toolbox for Action and...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 63

State Aid - European Commission consults on proposed amendments to General Block Exemption Regulation - On 6 October 2021, the Commission opened its consultation with Member States and interested parties to comment on...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 62

European Commission consults Member States on future of State aid Temporary Framework - On 30 September 2021, the Commission launched its consultation with Member States on a draft proposal to prolong the State aid...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 61

European Commission releases State of the Union 2021 report, including on COVID-related State aid - On 15 September 2021, the Commission published the State of the Union 2021 report on the Commission’s work and...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 60

European Commission responds to concerns regarding pandemic-related State aid support - On 20 August 2021, Commission Vice-President and Competition Commissioner Margrethe Vestager replied to a written question from June...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 59

This regular update (no. 59 | 16 August 2021) covers key regulatory EU developments related to the evolving COVID-19 situation (Antitrust & State Aid; Trade/Export Controls; Medicines, Medical Devices and Personal Protective...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 58

This regular alert covers key regulatory EU developments related to the COVID-19 situation. It does not purport to provide an exhaustive overview of developments and contains no analysis or opinion. LATEST KEY DEVELOPMENTS...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 57

This regular alert covers key regulatory EU developments related to the COVID-19 situation. It does not purport to provide an exhaustive overview of developments and contains no analysis or opinion. LATEST KEY DEVELOPMENTS...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 56

This regular alert covers key regulatory EU developments related to the COVID-19 situation. It does not purport to provide an exhaustive overview of developments and contains no analysis or opinion. LATEST KEY DEVELOPMENTS...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 55

This regular alert covers key regulatory EU developments related to the COVID-19 situation. It does not purport to provide an exhaustive overview of developments and contains no analysis or opinion. LATEST KEY DEVELOPMENTS...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 54

This regular alert covers key regulatory EU developments related to the COVID-19 situation. It does not purport to provide an exhaustive overview of developments and contains no analysis or opinion. LATEST KEY DEVELOPMENTS...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 53

This regular alert covers key regulatory EU developments related to the COVID-19 situation. It does not purport to provide an exhaustive overview of developments and contains no analysis or opinion. LATEST KEY DEVELOPMENTS...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 52

LATEST KEY DEVELOPMENTS - Competition & State Aid - • European Commission adopts first positive assessments of Recovery and Resilience Plans from 8 Member States • European Commission approves new and amended Member...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 51

LATEST KEY DEVELOPMENTS - Competition & State Aid - • Executive Vice-President and Competition Commissioner Margrethe Vestager addresses competition policy’s role in supporting Europe’s recovery • EU General Court...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 50

This regular alert covers key regulatory EU developments related to the COVID-19 situation. It does not purport to provide an exhaustive overview of developments and contains no analysis or opinion. LATEST KEY DEVELOPMENTS...more

The EU Pharma Incentives Review—Two Studies and a Legislative Proposal Released

The Situation: On May 28 and 29, 2018, the European Commission ("Commission") published two studies aimed at examining the economic and legal impacts of the European Union's regime on Supplementary Protection Certificates...more

FDA Reorganizes ORA Staff, Pharmaceutical & Medical Device Update, Vol. IV, Issue III

On May 15, 2017, the Food and Drug Administration's ("FDA" or "Agency") Office of Regulatory Affairs ("ORA") began implementing a "Program Alignment Initiative." The Initiative requires the ORA staff, who are charged with...more

44 Results
 / 
View per page
Page: of 2

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide